Skip to content

Phase I study of nanoparticle curcumin

Phase I study of nanoparticle curcumin - Phase I study of nanoparticle curcumin

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000003488
Enrollment
6
Registered
2010-05-10
Start date
2010-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteer

Interventions

Intake of nanoparticle curcumin

Sponsors

Kyoto University Hospital, Outpatient Oncology Unit
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy volunteeer who provided written informed consent

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
To evaluate the pharmacokinetic variables including Cmax, T1/2 and AUC after nanoparticle curcumin intake

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026